Global Molecular Imaging Equipment Market Growth 2023-2029

The global Molecular Imaging Equipment market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Molecular Imaging Equipment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Molecular Imaging Equipment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Molecular Imaging Equipment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Molecular Imaging Equipment players cover Siemens Healthineers, GE HealthCare, Royal Philips, BRUKER, Cytiva, Bio-Rad, Thermo Fisher Scientific and VILBER, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

Researcher's newest research report, the “Molecular Imaging Equipment Industry Forecast” looks at past sales and reviews total world Molecular Imaging Equipment sales in 2022, providing a comprehensive analysis by region and market sector of projected Molecular Imaging Equipment sales for 2023 through 2029. With Molecular Imaging Equipment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Molecular Imaging Equipment industry.

This Insight Report provides a comprehensive analysis of the global Molecular Imaging Equipment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Molecular Imaging Equipment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Molecular Imaging Equipment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Molecular Imaging Equipment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Molecular Imaging Equipment.

This report presents a comprehensive overview, market shares, and growth opportunities of Molecular Imaging Equipment market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

SPECT and CT Scanner

PET and CT Scanner

Segmentation by application

Medicine

Biopharmaceutical

Chemical

Others

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

Siemens Healthineers

GE HealthCare

Royal Philips

BRUKER

Cytiva

Bio-Rad

Thermo Fisher Scientific

VILBER

Key Questions Addressed in this Report

What is the 10-year outlook for the global Molecular Imaging Equipment market?

What factors are driving Molecular Imaging Equipment market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Molecular Imaging Equipment market opportunities vary by end market size?

How does Molecular Imaging Equipment break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?